107 related articles for article (PubMed ID: 12101423)
1. The ability of Fos family members to produce phenotypic changes in epithelioid cells is not directly linked to their transactivation potentials.
Andersen H; Mahmood S; Tkach V; Cohn M; Kustikova O; Grigorian M; Berezin V; Bock E; Lukanidin E; Tulchinsky E
Oncogene; 2002 Jul; 21(31):4843-8. PubMed ID: 12101423
[TBL] [Abstract][Full Text] [Related]
2. Role of the Fos family members, c-Fos, Fra-1 and Fra-2, in the regulation of cell motility.
Tkach V; Tulchinsky E; Lukanidin E; Vinson C; Bock E; Berezin V
Oncogene; 2003 Aug; 22(32):5045-54. PubMed ID: 12902987
[TBL] [Abstract][Full Text] [Related]
3. Expression and distribution of AP-1 transcription factors in the porcine ovary.
Rusovici R; LaVoie HA
Biol Reprod; 2003 Jul; 69(1):64-74. PubMed ID: 12606371
[TBL] [Abstract][Full Text] [Related]
4. Fos-related antigen 1 modulates malignant features of glioma cells.
Debinski W; Gibo DM
Mol Cancer Res; 2005 Apr; 3(4):237-49. PubMed ID: 15831677
[TBL] [Abstract][Full Text] [Related]
5. Tissue-specific expression of the fos-related transcription factor fra-2 during mouse development.
Carrasco D; Bravo R
Oncogene; 1995 Mar; 10(6):1069-79. PubMed ID: 7700631
[TBL] [Abstract][Full Text] [Related]
6. Fos family members: regulation, structure and role in oncogenic transformation.
Tulchinsky E
Histol Histopathol; 2000 Jul; 15(3):921-8. PubMed ID: 10963134
[TBL] [Abstract][Full Text] [Related]
7. Constitutive activation of nuclear factor kappaB p50/p65 and Fra-1 and JunD is essential for deregulated interleukin 6 expression in prostate cancer.
Zerbini LF; Wang Y; Cho JY; Libermann TA
Cancer Res; 2003 May; 63(9):2206-15. PubMed ID: 12727841
[TBL] [Abstract][Full Text] [Related]
8. Apoptosis during castration-induced regression of the prostate is Fos dependent.
Feng Z; Joos HJ; Vallan C; Mühlbauer R; Altermatt HJ; Jaggi R
Oncogene; 1998 Nov; 17(20):2593-600. PubMed ID: 9840922
[TBL] [Abstract][Full Text] [Related]
9. Pdcd4 suppresses tumor phenotype in JB6 cells by inhibiting AP-1 transactivation.
Yang HS; Knies JL; Stark C; Colburn NH
Oncogene; 2003 Jun; 22(24):3712-20. PubMed ID: 12802278
[TBL] [Abstract][Full Text] [Related]
10. Ubiquitin-independent proteasomal degradation of Fra-1 is antagonized by Erk1/2 pathway-mediated phosphorylation of a unique C-terminal destabilizer.
Basbous J; Chalbos D; Hipskind R; Jariel-Encontre I; Piechaczyk M
Mol Cell Biol; 2007 Jun; 27(11):3936-50. PubMed ID: 17371847
[TBL] [Abstract][Full Text] [Related]
11. Ubiquitin-independent- versus ubiquitin-dependent proteasomal degradation of the c-Fos and Fra-1 transcription factors: is there a unique answer?
Basbous J; Jariel-Encontre I; Gomard T; Bossis G; Piechaczyk M
Biochimie; 2008 Feb; 90(2):296-305. PubMed ID: 17825471
[TBL] [Abstract][Full Text] [Related]
12. Interaction with GATA transcription factors provides a mechanism for cell-specific effects of c-Fos.
McBride K; Charron F; Lefebvre C; Nemer M
Oncogene; 2003 Nov; 22(52):8403-12. PubMed ID: 14627981
[TBL] [Abstract][Full Text] [Related]
13. Fra-1 negatively regulates lipopolysaccharide-mediated inflammatory responses.
Morishita H; Saito F; Kayama H; Atarashi K; Kuwata H; Yamamoto M; Takeda K
Int Immunol; 2009 Apr; 21(4):457-65. PubMed ID: 19251936
[TBL] [Abstract][Full Text] [Related]
14. c-Fos is required for TGFbeta1 production and the associated paracrine migratory effects of human colon carcinoma cells.
Liu G; Ding W; Liu X; Mulder KM
Mol Carcinog; 2006 Aug; 45(8):582-93. PubMed ID: 16637060
[TBL] [Abstract][Full Text] [Related]
15. FRA-1 expression level regulates proliferation and invasiveness of breast cancer cells.
Belguise K; Kersual N; Galtier F; Chalbos D
Oncogene; 2005 Feb; 24(8):1434-44. PubMed ID: 15608675
[TBL] [Abstract][Full Text] [Related]
16. Tissue-specific transgenic knockdown of Fos-related antigen 2 (Fra-2) expression mediated by dominant negative Fra-2.
Smith M; Burke Z; Humphries A; Wells T; Klein D; Carter D; Baler R
Mol Cell Biol; 2001 Jun; 21(11):3704-13. PubMed ID: 11340164
[TBL] [Abstract][Full Text] [Related]
17. Characterization of E-cadherin-dependent and -independent events in a new model of c-Fos-mediated epithelial-mesenchymal transition.
Mejlvang J; Kriajevska M; Berditchevski F; Bronstein I; Lukanidin EM; Pringle JH; Mellon JK; Tulchinsky EM
Exp Cell Res; 2007 Jan; 313(2):380-93. PubMed ID: 17141758
[TBL] [Abstract][Full Text] [Related]
18. [Tumor cell proteins, detected using antibodies to the S- and N-terminal fragments of the fos proto-oncogene product].
Mazurenko NN; Kiseleva NP; Kudriavets IuI; Mikhaleva II; Antonenko VV; Kiselev FL
Mol Biol (Mosk); 1990; 24(5):1351-62. PubMed ID: 2127073
[TBL] [Abstract][Full Text] [Related]
19. Mesothelial cell transformation requires increased AP-1 binding activity and ERK-dependent Fra-1 expression.
Ramos-Nino ME; Timblin CR; Mossman BT
Cancer Res; 2002 Nov; 62(21):6065-9. PubMed ID: 12414630
[TBL] [Abstract][Full Text] [Related]
20. Fra-1 induces morphological transformation and increases in vitro invasiveness and motility of epithelioid adenocarcinoma cells.
Kustikova O; Kramerov D; Grigorian M; Berezin V; Bock E; Lukanidin E; Tulchinsky E
Mol Cell Biol; 1998 Dec; 18(12):7095-105. PubMed ID: 9819396
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
